Veratridine is a steroidal alkaloid found in plants of the lily family, specifically the genera Veratrum and Schoenocaulon. Upon absorption through the skin or mucous membranes, it acts as a neurotoxin by binding to and preventing the inactivation of voltage-gated sodium ion channels in heart, nerve, and skeletal muscle cell membranes. Veratridine increases nerve excitability and intracellular Ca2+ concentrations.
3D model (JSmol)
|Molar mass||673.80 g·mol−1|
|Melting point||160 to 180 °C (320 to 356 °F; 433 to 453 K)|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|what is ?)(|
Veratridine has been isolated from the seeds of Schoenocaulon officinale and from the rhizomes of Veratrum album. Like the other steroidal alkaloids found in these plants and similar ones in the Melanthiaceae family, it is present as part of a glycosidal combination, bonded to carbohydrate moieties.
Early isolation methods relied on formation of the nitrate salt and then precipitation of the insoluble sulfate form. Accounts of these efforts date back to 1878, but the first true purification of veratridine is the one carried out in 1953 by Kupchan et al. This, and later purification procedures, begin with veratrine, a mixture of the alkaloids present in the Veratrum plants, primarily containing cevadine and veratridine. The nitrate salt is formed by dissolving the veratrine in 1% sulfuric acid over ice and precipitating with sodium nitrate. After resuspending in water over ice, the solution is brought to pH 8.5 with aqueous NaOH and then pH 10 with aqueous ammonia, forming another precipitate with is extracted with ether and then with chloroform. The ether and chloroform fractions are combined and dried. The dried residue is dissolved in sulfuric acid and the sulfate salt of veratridine is precipitated by dropwise addition of a solution of ammonium sulfate. Finally, the free base form is generated with ammonium hydroxide.
An even better isolation of veratridine from veratrine is achieved using high-performance liquid chromatography (HPLC); as commercially available veratridine may vary in purity, HPLC purification of veratrine is a preferred method for isolation of veratridine for biological studies.
Veratridine is a derivative, the 3-veratroate ester, of veracevine, which belongs to the class of C-nor-D-homosteroidal alkaloids. The molecular structure and stereochemistry of this and related alkaloids were only established after decades of chemical investigations. The structure of veratridine has been confirmed by NMR spectroscopy and X-ray crystallography.
Veratridine displays an unusual steroidal backbone. In the typical four-ring nucleus with three six-membered rings and one five-membered ring (like the one in cholesterol), the five-membered ring is on the end. Veratridine, and other Veratrum alkaloids, have the five-membered ring between the second and third six-membered rings.
Veratridine has a pKa of 9.54. It is slightly soluble in ether, soluble in ethanol and DMSO, and freely soluble in chloroform. Solubility in water is pH-dependent; the free base form is slightly soluble, but easily dissolves in 1 M HCl. Its nitrate salt is slightly soluble in water. Its sulfate salt is very hygroscopic.
Mechanism of Action and ApplicationsEdit
Veratridine acts a neurotoxin by increasing nerve excitability. It binds to binding site 2 on the voltage-gated sodium channels (the same site bound by batrachotoxin, aconitine, and grayanotoxin), leading to persistent activation. Veratridine inhibits sodium channel inactivation by shifting the activation threshold toward a more negative potential. The resulting influx of Na+ also leads to the increase of intracellular Ca2+ concentrations, causing the overproduction of reactive oxygen species responsible for neuronal damage.
Veratridine is readily absorbed through the skin and mucous membranes and through ingestion. The tissues most affected are the heart, nerves, and skeletal muscles: main symptoms of veratridine toxicity include severe nausea, bradycardia, hypotension, difficulty breathing, salivation, and muscle weakness. Treatment involves the administration of activated charcoal, atropine, and benzodiazepines (if the affected individual is seizing).
Veratridine’s ability to depolarize cells by affecting sodium channels lends it its applicability as a neuropharmacological tool for the study of electrical properties of nerve and muscle fibers. It has also been tested as a treatment for myasthenia gravis, in light of its potential to increase muscle responses to motor neuron stimulation.
- "Steroidal Alkaloids". Pharmacognosy | Plants | herbal | herb | traditional medicine | alternative | Botany. Retrieved 2018-05-02.
- Ujváry, István (2010). Hayes' Handbook of Pesticide Toxicology. Elsevier. pp. 119–229. doi:10.1016/b978-0-12-374367-1.00003-3. ISBN 9780123743671.
- Reed, Juta K.; Gerrie, Jacqualine; Reed, Kenton L. (January 1986). "Purification of veratridine from veratrine using high-performance liquid chromatography". Journal of Chromatography A. 356: 450–454. doi:10.1016/s0021-9673(00)91516-4. ISSN 0021-9673.
- McKinney, L. C.; Chakraverty, S.; De Weer, P. (1986-02-15). "Purification, solubility, and pKa of veratridine". Analytical Biochemistry. 153 (1): 33–38. ISSN 0003-2697. PMID 3963380.
- S. M. Kupchan (1968). "Chapter 2 Steroid Alkaloids: The Veratrum Group". In R. H. F. Manske. The Alkaloids: Chemistry and Physiology. 10. New York: Academic Press. pp. 193–285. doi:10.1016/S1876-0813(08)60254-7. ISBN 978-0-12-469510-8.
- V. V. Krishnamurthy; J. E. Casida (1988). "Complete spectral assignments of cevadine and veratridine by 2D NMR techniques". Magn. Reson. Chem. 26 (11): 980–989. doi:10.1002/mrc.1260261109.
- P. W. Codding (1983). "Structural studies of sodium channel neurotoxins. 2. Crystal structure and absolute configuration of veratridine perchlorate". J. Am. Chem. Soc. 105 (10): 3172–3176. doi:10.1021/ja00348a035.
- "Product Information: Veratridine" (PDF). Sigma Aldrich. Retrieved May 2, 2018.
- The Merck Index (10th ed.). Rahway: Merck & Co. 1983. p. 1422.
- Denac, H.; Mevissen, M.; Scholtysik, G. (December 2000). "Structure, function and pharmacology of voltage-gated sodium channels". Naunyn-Schmiedeberg's Archives of Pharmacology. 362 (6): 453–479. ISSN 0028-1298. PMID 11138838.
- Fekete, Ádám; Franklin, Laura; Ikemoto, Takeshi; Rózsa, Balázs; Lendvai, Balázs; Sylvester Vizi, E.; Zelles, Tibor (2009-08-31). "Mechanism of the persistent sodium current activator veratridine-evoked Ca2+elevation: implication for epilepsy". Journal of Neurochemistry. 111 (3): 745–756. doi:10.1111/j.1471-4159.2009.06368.x. ISSN 0022-3042.
- "VERATRIDINE - National Library of Medicine HSDB Database". toxnet.nlm.nih.gov. Retrieved 2018-05-02.